• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

具有相同复合杂合性PARK2突变的兄弟姐妹中的表型不一致

Phenotypic Discordance in Siblings with Identical Compound Heterozygous PARK2 Mutations.

作者信息

Isaacs David, Claassen Daniel, Bowman Aaron B, Hedera Peter

机构信息

Department of Neurology, Vanderbilt University Medical Center, 1301 Medical Center Dr. Suite 3930, Nashville, TN 37232-5400, USA.

Department of Pediatrics, Pediatric Neurology, Vanderbilt University Medical Center, Nashville, TN 37232-2594, USA.

出版信息

Brain Sci. 2017 Jun 24;7(7):71. doi: 10.3390/brainsci7070071.

DOI:10.3390/brainsci7070071
PMID:28672806
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5532584/
Abstract

mutations are the most common cause of early-onset Parkinson's disease. No genotype-phenotype correlation exists, and phenotypic variability is quite common. We report two siblings with confirmed identical compound heterozygous mutations in the gene manifesting strikingly different phenotypes. The older brother demonstrated marked parkinsonism by his mid-20's, whereas the younger brother developed exercise-induced dystonia in his mid-30's with no subsequent clinical progression, highlighting the clinical heterogeneity of the disease and implying the role of other genetic and/or environmental factors in disease progression. The younger sibling, despite his mild symptoms, had a clearly abnormal dopamine transporter (DaT)-SPECT scan. To our knowledge, this is the first such reported case of an abnormal DaT-SPECT scan in a patient with biallelic mutations who does not meet the clinical criteria for Parkinson's disease.

摘要

突变是早发性帕金森病最常见的病因。不存在基因型与表型的相关性,表型变异性相当常见。我们报告了两名兄弟姐妹,他们在该基因中具有经确认相同的复合杂合突变,但表现出截然不同的表型。哥哥在25岁左右出现明显的帕金森综合征,而弟弟在35岁左右出现运动诱发性肌张力障碍,且后续无临床进展,这突出了该疾病的临床异质性,并暗示了其他遗传和/或环境因素在疾病进展中的作用。弟弟尽管症状较轻,但多巴胺转运体(DaT)单光子发射计算机断层扫描(SPECT)结果明显异常。据我们所知,这是首例报道的双等位基因突变患者中DaT-SPECT扫描异常但不符合帕金森病临床标准的病例。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d104/5532584/660d4b13c7af/brainsci-07-00071-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d104/5532584/2f234ad58365/brainsci-07-00071-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d104/5532584/660d4b13c7af/brainsci-07-00071-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d104/5532584/2f234ad58365/brainsci-07-00071-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d104/5532584/660d4b13c7af/brainsci-07-00071-g002.jpg

相似文献

1
Phenotypic Discordance in Siblings with Identical Compound Heterozygous PARK2 Mutations.具有相同复合杂合性PARK2突变的兄弟姐妹中的表型不一致
Brain Sci. 2017 Jun 24;7(7):71. doi: 10.3390/brainsci7070071.
2
Han Chinese family with early-onset Parkinson's disease carries novel compound heterozygous mutations in the PARK2 gene.一个有早发性帕金森病的汉族家庭携带 PARK2 基因的新型复合杂合突变。
Brain Behav. 2019 Sep;9(9):e01372. doi: 10.1002/brb3.1372. Epub 2019 Aug 6.
3
Analysis of Dosage Mutation in PARK2 among Korean Patients with Early-Onset or Familial Parkinson's Disease.分析早发性或家族性帕金森病韩国患者中 PARK2 基因的剂量突变。
J Clin Neurol. 2014 Jul;10(3):244-8. doi: 10.3988/jcn.2014.10.3.244. Epub 2014 Jul 3.
4
[A childhood-onset rapid-onset dystonia parkinsonism family with ATP1A3 gene mutation and literatures review].[一个伴有ATP1A3基因突变的儿童期起病的快速进展性肌张力障碍帕金森综合征家系及文献复习]
Zhonghua Er Ke Za Zhi. 2017 Apr 2;55(4):288-293. doi: 10.3760/cma.j.issn.0578-1310.2017.04.011.
5
Identification of mutations in the PARK2 gene in Serbian patients with Parkinson's disease.在塞尔维亚帕金森病患者中 PARK2 基因突变的鉴定。
J Neurol Sci. 2018 Oct 15;393:27-30. doi: 10.1016/j.jns.2018.07.020. Epub 2018 Jul 24.
6
[Etiology and pathogenesis of Parkinson's disease: from mitochondrial dysfunctions to familial Parkinson's disease].帕金森病的病因与发病机制:从线粒体功能障碍到家族性帕金森病
Rinsho Shinkeigaku. 2004 Apr-May;44(4-5):241-62.
7
A wide variety of mutations in the parkin gene are responsible for autosomal recessive parkinsonism in Europe. French Parkinson's Disease Genetics Study Group and the European Consortium on Genetic Susceptibility in Parkinson's Disease.在欧洲,帕金森病基因(parkin基因)中的多种突变是常染色体隐性帕金森综合征的病因。法国帕金森病遗传学研究小组和欧洲帕金森病遗传易感性联盟。
Hum Mol Genet. 1999 Apr;8(4):567-74. doi: 10.1093/hmg/8.4.567.
8
Genetic mutations in early-onset Parkinson's disease Mexican patients: molecular testing implications.早发性帕金森病墨西哥患者的基因突变:分子检测的意义。
Am J Med Genet B Neuropsychiatr Genet. 2014 Apr;165B(3):235-44. doi: 10.1002/ajmg.b.32228. Epub 2014 Feb 23.
9
A Peruvian family with a novel PARK2 mutation: Clinical and pathological characteristics.一个携带新型PARK2突变的秘鲁家庭:临床和病理特征
Parkinsonism Relat Disord. 2015 May;21(5):444-8. doi: 10.1016/j.parkreldis.2015.01.005. Epub 2015 Jan 15.
10
Low frequency of Parkin, Tyrosine Hydroxylase, and GTP Cyclohydrolase I gene mutations in a Danish population of early-onset Parkinson's Disease.丹麦早发性帕金森病患者中帕金、酪氨酸羟化酶和GTP环化水解酶I基因突变的低频率
Eur J Neurol. 2006 Apr;13(4):385-90. doi: 10.1111/j.1468-1331.2006.01249.x.

引用本文的文献

1
Phase Determination and Demonstration of Parental Mosaicism of Intragenic Deletions Initially Identified by Chromosomal Microarray Analysis.最初通过染色体微阵列分析鉴定的基因内缺失的相位确定及亲代嵌合现象的证实
Genes (Basel). 2025 May 24;16(6):630. doi: 10.3390/genes16060630.
2
Genomic, transcriptomic, and metabolomic profiles of hiPSC-derived dopamine neurons from clinically discordant brothers with identical PRKN deletions.来自具有相同PRKN缺失的临床症状不一致的兄弟的人诱导多能干细胞衍生多巴胺神经元的基因组、转录组和代谢组图谱。
NPJ Parkinsons Dis. 2022 Jun 29;8(1):84. doi: 10.1038/s41531-022-00346-3.
3
Parkin Pleiotropy: Extremely Atypical Phenotypes in Patients With Compound Heterozygous Mutations.

本文引用的文献

1
The roles of PINK1, parkin, and mitochondrial fidelity in Parkinson's disease.PINK1、parkin 和线粒体保真度在帕金森病中的作用。
Neuron. 2015 Jan 21;85(2):257-73. doi: 10.1016/j.neuron.2014.12.007.
2
PARK2 patient neuroprogenitors show increased mitochondrial sensitivity to copper.帕金森病2型(PARK2)患者的神经前体细胞对铜的线粒体敏感性增加。
Neurobiol Dis. 2015 Jan;73:204-12. doi: 10.1016/j.nbd.2014.10.002. Epub 2014 Oct 12.
3
Environmental toxins and Parkinson's disease.环境毒素与帕金森病。
Parkin 多效性:复合杂合突变患者的极非典型表型。
Tremor Other Hyperkinet Mov (N Y). 2020 Aug 13;10:26. doi: 10.5334/tohm.55.
4
Deep brain stimulation and genetic variability in Parkinson's disease: a review of the literature.帕金森病中的脑深部电刺激与基因变异性:文献综述
NPJ Parkinsons Dis. 2019 Sep 6;5:18. doi: 10.1038/s41531-019-0091-7. eCollection 2019.
Annu Rev Pharmacol Toxicol. 2014;54:141-64. doi: 10.1146/annurev-pharmtox-011613-135937. Epub 2013 Sep 16.
4
Monogenic Parkinson's disease and parkinsonism: clinical phenotypes and frequencies of known mutations.单基因帕金森病和帕金森综合征:已知突变的临床表型和频率。
Parkinsonism Relat Disord. 2013 Apr;19(4):407-15. doi: 10.1016/j.parkreldis.2013.01.020. Epub 2013 Feb 23.
5
Parkin disease: a clinicopathologic entity?帕金森病:一种临床病理实体?
JAMA Neurol. 2013 May;70(5):571-9. doi: 10.1001/jamaneurol.2013.172.
6
Phenotypic variability of parkin mutations in single kindred.单一家系中 parkin 基因突变的表型变异性。
Mov Disord. 2012 Sep 1;27(10):1299-303. doi: 10.1002/mds.25041. Epub 2012 Jul 17.
7
The role of parkin in familial and sporadic Parkinson's disease.帕金森病中 parkin 基因的作用:家族性与散发性帕金森病。
Mov Disord. 2010;25 Suppl 1(0 1):S32-9. doi: 10.1002/mds.22798.
8
Parkinson's disease: from monogenic forms to genetic susceptibility factors.帕金森病:从单基因形式到遗传易感性因素
Hum Mol Genet. 2009 Apr 15;18(R1):R48-59. doi: 10.1093/hmg/ddp012.
9
Parkinson's disease: clinical features and diagnosis.帕金森病:临床特征与诊断
J Neurol Neurosurg Psychiatry. 2008 Apr;79(4):368-76. doi: 10.1136/jnnp.2007.131045.
10
Influence of heterozygosity for parkin mutation on onset age in familial Parkinson disease: the GenePD study.帕金森病相关基因parkin杂合突变对家族性帕金森病发病年龄的影响:基因帕金森病(GenePD)研究
Arch Neurol. 2006 Jun;63(6):826-32. doi: 10.1001/archneur.63.6.826.